{"id":"https://openalex.org/W82180628","doi":null,"title":"Current strategies for anticancer chemoprevention and chemoprotection.","display_name":"Current strategies for anticancer chemoprevention and chemoprotection.","alternate_titles":[],"publication_year":2002,"publication_date":"2002-11-01","ids":{"openalex":"https://openalex.org/W82180628","mag":"82180628","pmid":"https://pubmed.ncbi.nlm.nih.gov/12669776"},"language":"en","primary_location":{"id":"pmid:12669776","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12669776","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta poloniae pharmaceutica","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W82180628"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113841056","display_name":"Krzysztof L. Krzystyniak","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I159129438","display_name":"Universit\u00e9 du Qu\u00e9bec \u00e0 Montr\u00e9al","ror":"https://ror.org/002rjbv21","country_code":"CA","type":"education","lineage":["https://openalex.org/I159129438","https://openalex.org/I49663120"]}],"countries":["CA"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Krzysztof L Krzystyniak","raw_affiliation_strings":["Department of Biological Sciences, University of Quebec-Montreal, Montreal, Canada H3C 3P8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biological Sciences, University of Quebec-Montreal, Montreal, Canada H3C 3P8","institution_ids":["https://openalex.org/I159129438"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5113841056"],"corresponding_institution_ids":["https://openalex.org/I159129438"],"apc_list":null,"apc_paid":null,"fwci":0.8335,"has_fulltext":false,"cited_by_count":34,"citation_normalized_percentile":{"value":0.72059209,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":96},"biblio":{"volume":"59","issue":"6","first_page":"473","last_page":"478"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.482699990272522,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.482699990272522,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.062199998646974564,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T14135","display_name":"Cancer and biochemical research","score":0.050200000405311584,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chemoprevention","display_name":"chemoprevention","score":0.9760000109672546},{"id":"https://openalex.org/keywords/chemoprotection","display_name":"chemoprotection","score":0.9810000061988831},{"id":"https://openalex.org/keywords/preventive-oncology","display_name":"preventive oncology","score":0.8080000281333923},{"id":"https://openalex.org/keywords/carcinogenesis","display_name":"carcinogenesis","score":0.6499999761581421},{"id":"https://openalex.org/keywords/selective-estrogen-receptor-modulators","display_name":"selective estrogen receptor modulators","score":0.8970000147819519},{"id":"https://openalex.org/keywords/ppargamma","display_name":"PPAR\u03b3","score":0.7350000143051147},{"id":"https://openalex.org/keywords/aromatase-inhibition","display_name":"aromatase inhibition","score":0.9300000071525574},{"id":"https://openalex.org/keywords/5alpha-reductase-inhibition","display_name":"5\u03b1-reductase inhibition","score":0.9739999771118164},{"id":"https://openalex.org/keywords/cox-2-inhibition","display_name":"COX-2 inhibition","score":0.968999981880188},{"id":"https://openalex.org/keywords/inducible-nitric-oxide-synthase","display_name":"inducible nitric oxide synthase","score":0.9359999895095825},{"id":"https://openalex.org/keywords/phase-ii-detoxification","display_name":"phase II detoxification","score":0.7419999837875366},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.8579999804496765},{"id":"https://openalex.org/keywords/gene-therapy","display_name":"gene therapy","score":0.753000020980835},{"id":"https://openalex.org/keywords/lung-cancer-prevention","display_name":"lung cancer prevention","score":0.5839999914169312},{"id":"https://openalex.org/keywords/smoking-cessation","display_name":"smoking cessation","score":0.6949999928474426},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.6019999980926514},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.9959999918937683}],"concepts":[{"id":"https://openalex.org/C2776166826","wikidata":"https://www.wikidata.org/wiki/Q415287","display_name":"Aromatase","level":4,"score":0.6255097985267639},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5946986079216003},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5430256128311157},{"id":"https://openalex.org/C2777944059","wikidata":"https://www.wikidata.org/wiki/Q903917","display_name":"Selective estrogen receptor modulator","level":5,"score":0.5293987989425659},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4889878034591675},{"id":"https://openalex.org/C555283112","wikidata":"https://www.wikidata.org/wiki/Q1637543","display_name":"Carcinogenesis","level":3,"score":0.4828775227069855},{"id":"https://openalex.org/C84606932","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Estrogen receptor","level":4,"score":0.46797019243240356},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4670523405075073},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.42631810903549194},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.39217609167099},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.27394813299179077}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007249","descriptor_name":"Inflammation","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D011453","descriptor_name":"Prostaglandins","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D014157","descriptor_name":"Transcription Factors","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D016588","descriptor_name":"Anticarcinogenic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018160","descriptor_name":"Receptors, Cytoplasmic and Nuclear","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D018168","descriptor_name":"Receptors, Retinoic Acid","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D019883","descriptor_name":"Alkyl and Aryl Transferases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D020845","descriptor_name":"Selective Estrogen Receptor Modulators","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047072","descriptor_name":"Aromatase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047488","descriptor_name":"Retinoid X Receptors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051231","descriptor_name":"Farnesyltranstransferase","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058891","descriptor_name":"5-alpha Reductase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:12669776","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12669776","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta poloniae pharmaceutica","raw_type":"Journal Article"},{"id":"mag:82180628","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12669776","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2328928939","https://openalex.org/W2103113315","https://openalex.org/W593488019","https://openalex.org/W2011124869","https://openalex.org/W1981551673","https://openalex.org/W2083690952","https://openalex.org/W79833968","https://openalex.org/W1982659608","https://openalex.org/W1969783942","https://openalex.org/W2155796352"],"abstract_inverted_index":{"Relatively":[0],"new":[1],"targets":[2,203],"in":[3,7,48,114,148,195,204],"drug":[4],"design":[5],"projects":[6],"cancer":[8,77,158,212],"pharmacology":[9],"include":[10,88],"cytostatic":[11],"agents,":[12],"immune":[13],"system":[14],"modulators,":[15],"and":[16,50,67,117,159,185,198,229],"angiogenesis":[17],"inhibitors.":[18],"Preventive":[19],"oncology":[20],"applies":[21],"pharmacological":[22],"agents":[23],"to":[24,33,64,79,130,136,144,155,163,207],"reverse,":[25],"retard,":[26],"or":[27],"halt":[28],"progression":[29],"of":[30,37,57,85,120,153,161,168,174,178,187,211,215],"neoplastic":[31],"cells":[32],"invasive":[34],"malignancy.":[35],"Prevention":[36],"cancer,":[38],"however,":[39],"can":[40,61],"be":[41,62],"accomplished":[42],"through":[43,83],"many":[44],"strategies,":[45],"including":[46],"changes":[47],"diet":[49],"lifestyle.":[51],"For":[52],"example,":[53],"the":[54,69,105,131,179,209],"vast":[55],"majority":[56],"lung":[58,76],"cancers":[59],"(80-90%)":[60],"attributed":[63],"cigarette":[65],"smoking":[66],"therefore,":[68],"most":[70],"effective":[71],"primary":[72],"preventive":[73,205],"strategy":[74],"for":[75,104],"is":[78],"quit":[80],"smoking.":[81],"Chemoprevention":[82],"interruption":[84],"multistage":[86],"careinogenesis":[87],"different":[89],"molecular":[90],"targets.":[91],"Selective":[92,124],"estrogen":[93,99],"receptor":[94,100,108],"modulators":[95,126],"(SERMs)":[96],"act":[97],"as":[98],"(ER)":[101],"agonists.":[102],"Ligands":[103],"peroxisome":[106],"proliferator-activated":[107],"gamma":[109],"(PPAR-gamma)":[110],"suppress":[111],"breast":[112,157],"carcinogenesis":[113],"experimental":[115,196],"models":[116,197],"induce":[118],"differentiation":[119],"human":[121],"liposarcoma":[122],"cells.":[123],"PPAR":[125],"(SPARMs),":[127],"by":[128,172],"analogy":[129],"SERM":[132],"concept,":[133],"are":[134,192],"designed":[135],"have":[137],"desired":[138],"effects":[139],"on":[140],"specific":[141],"genes":[142],"relevant":[143],"carcinogenesis.":[145],"Enzymatic":[146],"approach":[147],"endocrine-related":[149],"tumors":[150],"involve":[151,213],"inhibition":[152,160,173,177],"aromatase":[154],"prevent":[156,164],"5-alpha-reductase":[162],"prostate":[165],"cancer.":[166],"Down-regulation":[167],"inflammatory":[169],"prostaglandin":[170],"synthesis":[171],"cyclooxygenase-2":[175],"(COX-2).":[176],"inducible":[180],"nitric":[181],"oxide":[182],"synthase":[183],"(iNOS),":[184],"stimulation":[186],"phase":[188],"II":[189],"detoxication":[190],"system,":[191],"currently":[193],"examined":[194],"clinical":[199],"trials.":[200],"Overall,":[201],"potential":[202],"strategies":[206],"reduce":[208],"risk":[210],"agonists":[214],"endocrine":[216],"receptors,":[217],"factors":[218,221],"down-regulating":[219],"inflammation,":[220],"inducing":[222],"programmed":[223],"cell":[224],"death":[225],"(PCD)/apoptosis,":[226],"enzymatic":[227],"inhibitors":[228],"gene":[230],"therapy.":[231]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W82180628","counts_by_year":[{"year":2023,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
